Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com.
View Top Employees from Hanmi PharmaceuticalsWebsite | http://www.hanmi.co.kr/ |
Revenue | $1 billion |
Employees | 499 (302 on RocketReach) |
Founded | 1973 |
Address | 14 Wiryeseong-daero, Seoul, Seoul, KR |
Phone | (822) 410-9114 |
Fax | (822) 410-9259 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Health Care, Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Healthcare, Development of NME Pipeline based on Long-Acting Technology(LAPS, Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, Sales& Marketing in Korea/China |
Web Rank | 4 Million |
Keywords | Pharmaceutical Research, Drug Development And Manufacturing, Biotechnology, Healthcare Products, Pharmaceutical Innovation, Biopharmaceuticals, Generic Drugs |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 44 Companies, NAICS Code 45 Companies, NAICS Code 325 Companies |
Looking for a particular Hanmi Pharmaceuticals employee's phone or email?
The Hanmi Pharmaceuticals annual revenue was $1 billion in 2024.
SungChul Choi is the Director of Hanmi Pharmaceuticals.
302 people are employed at Hanmi Pharmaceuticals.
Hanmi Pharmaceuticals is based in Seoul, Seoul.
The NAICS codes for Hanmi Pharmaceuticals are [32, 44, 45, 325].
The SIC codes for Hanmi Pharmaceuticals are [28, 283].